Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  VEGFR/PDGFR dual kinase inhibitor X-82
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients with Pancreatic Neuroendocrine Tumors
Phase: Phase II, Phase I
Type: Treatment
Age: 18 andover
Trial IDs: 201303150, NCI-2013-00641, NCT01784861
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients with Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: UW13112, NCI-2014-00944, NCT02146222
Start Over